Irinotecan News and Research

RSS
Irinotecan hydrochloride is approved by the Food and Drug Administration (FDA) to be used with other drugs to treat colorectal cancer that has metastasized (spread to other parts of the body). It is also approved to treat metastatic colorectal cancer that has recurred (come back) or gotten worse after earlier chemotherapy. In addition to the uses that have been approved by the FDA, irinotecan hydrochloride is sometimes used to treat other types of cancer. Irinotecan hydrochloride is also being studied in the treatment of other types of cancer.
Drug study for brain cancer shows promising results

Drug study for brain cancer shows promising results

Avastin (bevacizumab) shows promise in phase II study of glioblastoma multiforme

Avastin (bevacizumab) shows promise in phase II study of glioblastoma multiforme

Gene screen patent brings 2007 Deal of Distinction Award to UChicagoTech

Gene screen patent brings 2007 Deal of Distinction Award to UChicagoTech

Avastin and chemo combo may offer hope for glioblastoma multiforme patients

Avastin and chemo combo may offer hope for glioblastoma multiforme patients

New chemotherapy regimen prolongs survival in difficult-to-treat childhood brainstem gliomas

New chemotherapy regimen prolongs survival in difficult-to-treat childhood brainstem gliomas

FDA should amend the product information for irinotecan

FDA should amend the product information for irinotecan

Sequential and combination chemotherapy equally effective in treating advanced colorectal cancer

Sequential and combination chemotherapy equally effective in treating advanced colorectal cancer

Gene test not needed if cancer drug irinotecan given in low dose

Gene test not needed if cancer drug irinotecan given in low dose

Predicting treatment responses earlier for brain tumor patients

Predicting treatment responses earlier for brain tumor patients

More effective therapies for individual cancers  - personalized medicine

More effective therapies for individual cancers - personalized medicine

Cetuximab improves survival and slows progression of colorectal cancer

Cetuximab improves survival and slows progression of colorectal cancer

Avastin slows growth of gliomas

Avastin slows growth of gliomas

Dendrimer-encapsulated camptothecins

Dendrimer-encapsulated camptothecins

Markey Cancer Center receives approval to test cancer drug DB-67

Markey Cancer Center receives approval to test cancer drug DB-67

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases

Tumour specific drugs may render therapies based on a tumor's anatomical location obsolete

Tumour specific drugs may render therapies based on a tumor's anatomical location obsolete

Studying the gene-expression profiles of patients with colorectal cancer might help predict their response to chemotherapy

Studying the gene-expression profiles of patients with colorectal cancer might help predict their response to chemotherapy

FDA gives greenlight for new treatment of head and neck cancer

FDA gives greenlight for new treatment of head and neck cancer

Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer

Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer

Expert highlights public health problem posed by colorectal cancer

Expert highlights public health problem posed by colorectal cancer